ArticleCardio-oncology (London, England)2024
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
Jian Chu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.